In a small study, authors reported that 83% of their 18 patients with schizophrenia and only 3.3% of 30 controls (p < 0.0001) had autoantibodies to folate receptor alpha (FRα), which blocked the transfer of MTHF into the brain (6). Here, FOLR1 is linked to schizophrenia.